共 79 条
[1]
Branche AR(2015)Respiratory syncytial virus infection in older adults: an under-recognized problem Drugs Aging 32 261-9
[2]
Falsey AR(2005)Respiratory syncytial virus infection in elderly and high-risk adults N Engl J Med 352 1749-59
[3]
Falsey AR(2012)Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008 Clin Infect Dis 54 1427-36
[4]
Hennessey PA(2015)Modelling estimates of the burden of respiratory syncytial virus infection in adults and the elderly in the United Kingdom BMC Infect Dis 15 443-15
[5]
Formica MA(2014)Estimates of mortality attributable to influenza and RSV in the United States during 1997–2009 by influenza type or subtype, age, cause of death, and risk status Influenza Other Respir Viruses 8 507-102
[6]
Cox C(2012)Respiratory syncytial virus infection in adult populations Infect Disord Drug Targets 12 98-92
[7]
Walsh EE(2014)An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization Vaccine 32 6485-32
[8]
Zhou H(2012)Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats PLoS One 7 e50852-22
[9]
Thompson WW(2013)Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine Vaccine 31 524-35
[10]
Viboud CG(2016)A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age J Infect Dis 213 411-26